Mode
Text Size
Log in / Sign up

Renal disease

Part of Kidney Diseases

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Renal disease

9 trials tracked for Renal disease: 3 in phase 3 or 4 and 1 with published results. The most-cited published study has 17 citations.

9Trials tracked
3Phase 3 & 4
0Recruiting
1With published results
Phase distribution
Phase 4 1 Phase 3 2 Phase 2 1 Phase 1 1 Other / NA 4
  1. Phase 4 Effect of Deep BLock on Intraoperative Surgical Conditions Completed · 17 cited
  2. Phase 3 PROCRIT Extended Dosing For Maintenance of Hemoglobin in Pre-Dialysis CKD Patients Completed
  3. Phase 3 Evaluation of Therapeutic Plasma Exchange (TPE) Procedure Using the AMICUS Device Completed
  4. Phase 2 Ides in Highly Sensitized (HS) Patients Awaiting Kidney Transplantation Completed
  5. Phase 1 Light for Renal Transplant Recipients Having a Sleep-Wake Dysregulation Completed
  6. N/A VasQ External Support for Arteriovenous Fistula Completed
Show 3 more trials
  1. N/A The Effect of Motivational Interviewing and Education Based on Watson's Theory of Human Caring in Hemodialysis Completed
  2. N/A A Culturally-Based Palliative Care Tele-consult Program for Rural Southern Elders Completed
  3. N/A Assess Safety and Performance of the Kronos Electrocautery Device for Electrocautery Procedures Following Coaxial Biopsy Procedures Completed

Showing the 9 most-cited and recently-updated of 9 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

What the trials found Updated — new results For clinicians

Renal disease: what the trials found

Therapeutic plasma exchange has been shown to achieve a significant percent efficiency of plasma removal during procedures, with results recorded at 81.9% and 75.2% (p<0.001) 3.

The use of epoetin alfa for managing hemoglobin levels showed consistent outcomes, with the proportion of weeks per patient maintaining a hemoglobin concentration between 10.0 and 11.9 g/dL remaining stable across treatment groups at 0.87, 0.88, and 0.83 4.

Surgical blocks utilizing rocuronium combined with atracurium or mivacurium resulted in significant improvements in Surgical Rating Scale scores (4; 4.7, p<0.001) and lower Postoperative Sedation Scores (2.0; 1.3) 2.

Recent results — preliminary, needs further review

  • VasQ was evaluated in a recent trial (N=144), though specific outcome data were not provided in the summary 1.

For the clinician treating this condition

  • Therapeutic plasma exchange is an established method for achieving high percentages of plasma removal during procedures 3.
  • Epoetin alfa maintains hemoglobin concentrations within a target range of 10.0 to 11.9 g/dL over extended treatment periods 4.
  • Surgical blocks with rocuronium and atracurium/mivacurium are associated with improved surgical ratings and reduced postoperative sedation 2.

AI synthesis of 4 cited trials, updated Jun 29, 2026. Informational only — not medical advice; trial data sourced from ClinicalTrials.gov. How we use AI.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Research across Kidney Diseases

Related studies from across the Kidney Diseases family.

Environmental cadmium exposure may cause male reproductive dysfunction through the renal-testis axis
Psychiatry Sys. Review
Environmental cadmium exposure may cause male reproductive dysfunction through the renal-testis axis Cadmium exposure may harm male fertility and kidney health
This narrative review of 40 animal studies synthesizes evidence on environmental cadmium exposure and its impact on male reproduction. The a…
Environmental cadmium exposure can damage the male reproductive system and kidneys, potentially leading to lower semen quality and other iss…
Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI
Allergy & Immunology Sys. Review
Programmed cell death pathways form a spatiotemporally regulated network driving tubular damage in renal IRI New research identifies key pathways driving acute kidney injury
This systematic review examines the roles of pyroptosis, ferroptosis, cuproptosis, and necroptosis as key mediators of inflammation and oxid…
Researchers have mapped out a complex network of cell death pathways that drive inflammation and damage in patients with acute kidney injury…
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates
Urology Meta-analysis
Fluoroless ultrasound-guided techniques lower complications in percutaneous nephrolithotomy with equivalent stone-free rates Fluoroless ultrasound guidance reduces complications during kidney stone surgery
This systematic review and meta-analysis of randomized studies evaluated fluoroless ultrasound-guided versus fluoroscopy-guided techniques f…
A meta-analysis of randomized trials shows that using ultrasound instead of X-ray guidance lowers overall complications for kidney stone rem…
Meta-analysis of RCTs shows mPCNL yields higher single-session stone-free rates than RIRS for medium renal stones
Urology Meta-analysis
Meta-analysis of RCTs shows mPCNL yields higher single-session stone-free rates than RIRS for medium renal stones Mini-PCNL clears kidney stones better than RIRS in one session
This meta-analysis of randomized controlled trials evaluated retrograde intrarenal surgery versus miniaturized percutaneous nephrolithotomy …
Mini-PCNL clears medium-sized kidney stones in one session more often than RIRS, but RIRS has fewer complications and shorter hospital stays…
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection
Cardiology Sys. Review
Narrative review on anthracycline cardiorenal toxicity and dexrazoxane protection Doctors seek better ways to protect heart and kidney health during cancer drug treatment
This narrative review synthesizes evidence on anthracycline-induced cardiorenal toxicity and dexrazoxane's protective role. The authors note…
Cancer treatments called anthracyclines can harm the heart and kidneys. This review explains why doctors need new strategies to keep patient…
Narrative review discusses exosomes for renal ischemia-reperfusion injury management and translational barriers
Drug Pipeline Sys. Review
Narrative review discusses exosomes for renal ischemia-reperfusion injury management and translational barriers Tiny Kidney Protectors May Shield Patients From Sudden Damage
This narrative review examines the potential of exosomes for managing renal ischemia-reperfusion injury. The authors discuss the scope of th…
• Exosomes might prevent kidney harm when blood flow returns • Helps surgery patients and trauma survivors avoid kidney failure • Still in l…
Meta-analysis links suprarenal aortic repair techniques to higher risk of permanent renal dialysis in AAA patients
Nephrology Meta-analysis
Meta-analysis links suprarenal aortic repair techniques to higher risk of permanent renal dialysis in AAA patients Large review shows kidney dialysis risk is higher when surgeons clamp above the kidney during aortic repair
This systematic review and meta-analysis evaluated the risk of permanent renal dialysis following various abdominal aortic aneurysm repair t…
A big study looked at over 72,000 patients having surgery for a bulging aorta. It found that operations touching the kidney area make kidney…
Narrative review on renal involvement in primary Sjögren's disease and therapeutic prospects
Allergy & Immunology Sys. Review
Narrative review on renal involvement in primary Sjögren's disease and therapeutic prospects Understanding kidney problems in primary Sjogren's disease patients needs more research
This narrative review synthesizes current knowledge on renal involvement in primary Sjögren's disease. It highlights that the pathogenic bas…
Doctors are still learning how kidneys get hurt in primary Sjogren's disease. Current treatments work by guesswork because the exact cause i…
Patient-specific 3D printed kidney models improved comprehension and satisfaction compared to conventional 2D CT scans in PCNL patients
Urology RCT
Patient-specific 3D printed kidney models improved comprehension and satisfaction compared to conventional 2D CT scans in PCNL patients 3D kidney models improve patient understanding before surgery
This randomized clinical study enrolled 40 individuals aged 18 to 80 planned for PCNL surgery.
A small study found that 3D printed kidney models significantly improved patient comprehension and satisfaction compared to standard 2D scan…
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study
Orthopedics & Sports Medicine Cohort
Surgical treatment for gouty tophi wounds associated with high healing rates in retrospective study Surgery may help heal gouty tophi wounds
This retrospective cohort study of 130 patients with gouty tophi wounds in China observed high wound healing rates following surgical interv…
A small study shows that surgical treatment, including wound cleaning and vacuum drainage, helped most patients with gouty tophi wounds heal…
Flexible suction sheath outperforms conventional sheath in renal stone surgery
Urology RCT
Flexible suction sheath outperforms conventional sheath in renal stone surgery Kidney Stone Surgery Just Got a Major Upgrade
In this randomized controlled trial of 217 adults with 14-27 mm renal stones undergoing retrograde intrarenal surgery, the flexible navigabl…
You wake up after surgery, groggy but relieved.
Chemotherapy-related renal injury incidence and risk factors in patients with malignant tumors
Rheumatology Cohort
Chemotherapy-related renal injury incidence and risk factors in patients with malignant tumors Kidney injury risk rises with age, diabetes, and certain chemo drugs
This retrospective cohort study of 152 patients with malignant tumors found an 18.42% incidence of chemotherapy-related renal injury (CRI).
A study of cancer patients found nearly 1 in 5 developed kidney injury after chemotherapy, with older age and diabetes among key risk factor…

Questions about Renal disease

Can proton pump medicine use cause drug problems for hospitalized renal disease patients?

Proton pump inhibitors (PPIs) can cause drug-related problems in hospitalized patients with kidney disease, including issues with drug selection, treatment duration, and interactions with other medications like antiplatelet agents.

Full answer →